Back
Eli Lilly Bets $950M on InduPro's Cancer Platform
Back
Stock News
Themes
Eli Lilly Bets $950M on InduPro's Cancer Platform
Donald Trump
Eli Lilly Bets $950M on InduPro's Cancer Platform
Edgen Stock
·
Jan 08 2026, 10:10
Share to
Share to
Copy link
LLY
+0.29%
source:
[1] InduPro Therapeutics Announces Strategic Collaboration with Lilly to Develop First-in-Class Bispecific/Multispecific Oncology Therapeutics Using InduPro’s Proximity-Guided Platform
Recommend
Citi Raises PBF Energy Target to $36 After 14.8% Stock Gain
Jan 17 2026, 06:20
Dow Appoints New CTO to Unify Tech and Sustainability Goals
Jan 17 2026, 06:10
Mediacom Founder Rocco Commisso Dies, Sparking Leadership Questions
Jan 17 2026, 06:05
Edgen Stock·Jan 08 2026, 10:10Edgen Stock·Jan 08 2026, 10:10
Edgen Stock·Jan 08 2026, 10:10